The Kineticos Difference

Kineticos invests in entrepreneurs and early-stage companies, providing deep expertise, industry knowledge, and a bench of proven experts to support them through
every stage of their life cycle.

Investment Focus

We partner with companies that offer unique, innovative, and IP-protected products and services with a focus on cell and gene therapy, oncology, neurosciences, rare diseases, and antimicrobial resistance (AMR).

Learn More

Contract Services & Enabling Technologies


Invest in CDMOs, equipment, and enabling technology companies

Antimicrobial Resistance


Invest in novel therapies, services, vaccine and diagnostic companies

Biotech & Medtech


Invest in advanced therapeutic and medical device companies



Form new companies to advance science and drug development


Team Overview

Kineticos is led by life sciences industry entrepreneurs, operators and investors with scientific, business, and operating expertise who have exited companies.

Our Team

New From Kineticos

Press Release
July 26, 2023

Kincell Bio Launches

Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies RALEIGH, N.C., AND…